» Authors » James Gossage

James Gossage

Explore the profile of James Gossage including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 259
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paine H, Chidambaram S, Johar A, Maynard N, Lagergren P, Griffiths E, et al.
Br J Surg . 2025 Feb; 112(2). PMID: 39982378
Background: Long-term symptom burden and health-related quality-of-life outcomes after curative oesophageal cancer treatment are poorly understood. Existing tools are cumbersome and do not address the post-treatment population specifically. The aim...
2.
Byrne B, Siaw-Acheampong K, Evans O, Taylor J, Huddy F, Nilsson M, et al.
Br J Surg . 2024 Dec; 111(12). PMID: 39657739
Background: Oesophago-gastric cancer surgery negatively affects quality of life with a high postoperative symptom burden. Several conditions that may be diagnosed and treated after surgery are recognised. However, consensus regarding...
3.
Giet L, Gossage J
Dis Esophagus . 2024 Oct; 38(1. PMID: 39436310
No abstract available.
4.
Markar S, Sgromo B, Evans R, Griffiths E, Alfieri R, Castoro C, et al.
Ann Surg . 2024 Jun; 280(4):650-658. PMID: 38904105
Objective: To evaluate prognostic differences between minimally invasive esophagectomy (MIE) and open esophagectomy (OE) in patients with surgery after a prolonged interval (>12 wk) following chemoradiotherapy (CRT). Background: Previously, we...
5.
di Pietro M, Trudgill N, Vasileiou M, Longcroft-Wheaton G, Phillips A, Gossage J, et al.
Gut . 2024 Mar; 73(6):897-909. PMID: 38553042
Barrett's oesophagus is the only known precursor to oesophageal adenocarcinoma, a cancer with very poor prognosis. The main risk factors for Barrett's oesophagus are a history of gastro-oesophageal acid reflux...
6.
Noor Z, Gossage J, Evans O, Cuffe R, The Guys St Thomas Oesophago-Gastric Research Group
Eur J Surg Oncol . 2024 Mar; 50(6):108046. PMID: 38537367
Introduction: Despite significant surgical advancements in the treatment of oesophago-gastric cancer (OGC), patients often experience a considerable decline in health-related quality of life postoperatively. Psychological factors, such as hypervigilance and...
7.
OShea R, Withey S, Owczarczyk K, Rookyard C, Gossage J, Godfrey E, et al.
Eur Radiol . 2024 Mar; 34(10):6919-6928. PMID: 38526750
Background: Personalising management of primary oesophageal adenocarcinoma requires better risk stratification. Lack of independent validation of proposed imaging biomarkers has hampered clinical translation. We aimed to prospectively validate previously identified...
8.
Jamindar P, Pope M, Gossage J
J Clin Med . 2024 Jan; 13(1). PMID: 38202148
Hereditary hemorrhagic telangiectasia (HHT) is a hereditary disease characterized by recurrent epistaxis, mucocutaneous telangiectasias, and visceral arteriovenous malformations. Multiple genetic mutations have been linked to this rare disease, including ENG,...
9.
Markar S, Menon N, Guidozzi N, Kontouli K, Mavridis D, Andreou A, et al.
Surg Endosc . 2023 Nov; 37(12):9013-9029. PMID: 37910246
Background: New evidence has emerged since latest guidelines on the management of paraesophageal hernia, and guideline development methodology has evolved. Members of the European Association for Endoscopic Surgery have prioritized...
10.
Knight W, Moore J, Whyte G, Zylstra J, Lane A, Pate J, et al.
Br J Surg . 2023 Aug; 110(12):1668-1672. PMID: 37611139
No abstract available.